Review
Nature Reviews Immunology 5, 215-229 (March 2005) | doi:10.1038/nri1573
Immunology of hepatitis B virus and hepatitis C virus infection
Barbara Rehermann1 & Michelina Nascimbeni1 About the authors
Abstract
More than 500 million people worldwide are persistently infected with the hepatitis B virus (HBV) and/or hepatitis C virus (HCV) and are at risk of developing chronic liver disease, cirrhosis and hepatocellular carcinoma. Despite many common features in the pathogenesis of HBV- and HCV-related liver disease, these viruses markedly differ in their virological properties and in their immune escape and survival strategies. This review assesses recent advances in our understanding of viral hepatitis, contrasts mechanisms of virus–host interaction in acute hepatitis B and hepatitis C, and outlines areas for future studies.
- View At a Glance
Author affiliations
- Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Room 9B16, 10 Center Drive, Bethesda, Maryland 20892, USA.
Correspondence to: Barbara Rehermann1 Email: Rehermann@nih.gov
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Unraveling hepatitis B virus infection of mice and men (and woodchucks and ducks)Nature Medicine News and Views (01 Oct 1999)
RESEARCH
Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept studyGene Therapy Scientific Correspondence
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis CNature Medicine Article (01 May 2000)
See all 29 matches for Research
